Search clinical trials for: ALA dehydratase deficient porphyria (ADP) (ALAD)
Total 60125 results
-
Samsung Medical CenterCompleted
-
PfizerCompleted
-
AstraZenecaCompleted
-
Calithera Biosciences, IncTerminatedClear Cell Renal Cell Carcinoma | Colorectal Cancer | Solid Tumor | CRC | TNBC - Triple-Negative Breast Cancer | ccRCC | RCCUnited States
-
Icahn School of Medicine at Mount SinaiNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
K-Group, Beta, Inc., a wholly owned subsidiary...RecruitingOvarian Cancer | Fallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal CarcinomaUnited States, France
-
National Cancer Institute, NaplesRecruitingBRCA Wild Type Platinum Sensitive Recurrent Ovarian CancerItaly
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)Australia
-
Tango Therapeutics, Inc.TerminatedBreast Cancer | Ovarian Cancer | Prostate Cancer | Pancreas Cancer | BRCA1 Mutation | BRCA-Mutated Ovarian Carcinoma | BRCA-Associated Breast Carcinoma | HRD Positive Advanced Ovarian CancerUnited States
-
BayerGlaxoSmithKlineTerminatedOvarian Cancer | Advanced Solid Tumors (Excluding Prostate Cancer)United States
-
University of Michigan Rogel Cancer CenterActive, not recruitingProstate CancerUnited States
-
zr Pharma & GmbHCompletedAdvanced Solid TumorJapan
-
Institut BergoniéNational Cancer Institute, FranceCompleted
-
PfizerMedivation, Inc.CompletedAdvanced Solid TumorsUnited States, Canada
-
Royal Marsden NHS Foundation TrustAstraZeneca; Institute of Cancer Research, United KingdomCompleted
-
PfizerMedivation, Inc.Completed
-
Australia New Zealand Gynaecological Oncology GroupBeiGeneWithdrawn
-
Leiden University Medical CenterUniversity Medical Center Groningen; Erasmus Medical CenterRecruitingBRCA1 Mutation | BRCA2 Mutation | Homologous Recombination Deficiency | Ovarian Neoplasm EpithelialNetherlands
-
German Breast GroupGlaxoSmithKline; Stemline Therapeutics, Inc.Not yet recruitingBRCA1 Mutation | BRCA2 Mutation | PALB2 Gene Mutation | Hormone Receptor Positive HER-2 Negative Breast Cancer | Advanced or Metastatic Breast CancerGermany
-
Nader SanaiGlaxoSmithKline; University of California, San Francisco; Barrow Neurological... and other collaboratorsRecruitingGlioma | Glioblastoma | Glioblastoma Multiforme | GBM | Glioma, Malignant | Glioblastoma Multiforme of BrainUnited States
-
Gruppo Oncologico del Nord-OvestRecruitingHead and Neck Squamous Cell CarcinomaItaly
-
Massachusetts General HospitalTesaro, Inc.RecruitingTriple Negative Breast Cancer | Residual DiseaseUnited States
-
AstraZenecaParexelApproved for marketing
-
National Taiwan University HospitalAstraZenecaRecruiting
-
Korea University Anam HospitalTakeda; Korean Cancer Study GroupNot yet recruiting
-
National University Hospital, SingaporeRecruitingAdvanced Refractory Solid Tumors | Advanced Triple Negative Breast Cancers | Metastatic Triple Negative Breast CancersSingapore
-
Institute of Cancer Research, United KingdomAstraZeneca; Cancer Research UKRecruitingGynaecological CancersUnited Kingdom
-
Dana-Farber Cancer InstituteTesaro, Inc.Active, not recruiting
-
Dantari, Inc.CompletedHER2-negative Metastatic Breast CancerUnited States
-
Matthew GalskyIcahn School of Medicine at Mount Sinai; AstraZenecaCompletedMetastatic Urothelial CancerUnited States
-
PfizerTerminated
-
The University of Hong KongRecruitingEndometrial CancerHong Kong
-
Wuhan UniversityNot yet recruitingRecurrent Small Cell Lung Cancer
-
University of UtahClovis Oncology, Inc.Terminated
-
Mario Negri Institute for Pharmacological ResearchNorth Eastern German Society of Gynaecological OncologyActive, not recruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaItaly, Germany
-
The University of Hong KongCompletedOvarian CancerHong Kong
-
AstraZenecaCompletedBRCA or HRR+ Mutated Ovarian Cancer PatientsItaly, Spain, Canada, Czechia, Poland, United Kingdom, Hungary, Bulgaria
-
Gustave Roussy, Cancer Campus, Grand ParisUnknownNon Small Cell Lung CancerFrance
-
Gustave Roussy, Cancer Campus, Grand ParisSuspended
-
Zhejiang Cancer HospitalSun Yat-sen University; Fujian Cancer Hospital; Hunan Cancer Hospital; Zhejiang... and other collaboratorsNot yet recruitingTriple Negative Breast Cancer | Homologous Recombination Deficiency
-
Memorial Sloan Kettering Cancer CenterClovis Oncology, Inc.Active, not recruiting
-
University of Texas Southwestern Medical CenterCompletedBreast Cancer | Ovarian CancerUnited States
-
AbbVieNo longer availableHigh Grade Serous Ovarian Cancer | Solid Tumors With Documented BRCA, BARD, or PALB or Other Acceptable DNA Mutations or Anomalies That Are Scientifically Sound | Triple Negative Breast Cancer (TNBC) | Patients Requiring Veliparib Suspension Formulation
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustUnknownAdenocarcinoma of the ProstateUnited Kingdom
-
National Institute of Allergy and Infectious Diseases...Not yet recruitingCongenital Cytomegalovirus Infection
-
Paul Mathew, MDHoosier Cancer Research Network; Tesaro, Inc.TerminatedMetastatic Prostate CancerUnited States
-
University of MiamiGlaxoSmithKlineNot yet recruiting
-
Sunnybrook Health Sciences CentreGlaxoSmithKlineRecruitingOvarian Cancer | Stage IV Ovarian Cancer | High Grade Ovarian Serous Adenocarcinoma | Stage III Ovarian CancerCanada
-
SOLTI Breast Cancer Research GroupRecruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | HER2-negative Breast CancerSpain
-
Ling-Ying WuNot yet recruiting